Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Clinical Roundup

Nanoparticle vaccine prevents melanoma, pancreatic, and breast cancers in mice, study finds

October 17, 2025
Vol.51 No.38
Clinical Roundup

Datroway improves OS as first-line therapy in metastatic TNBC, phase III trial shows

October 10, 2025
Vol.51 No.37
Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research
In Brief

Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research

October 03, 2025
Vol.51 No.36
In Brief

Northwell unveils $14M Center for Women’s Cancer

October 03, 2025
Vol.51 No.36
Drugs & Targets

FDA approves Inluriyo for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer

October 03, 2025
Vol.51 No.36
In Brief

UC Davis Health and UCLA co-lead $16M study of AI use in breast cancer diagnosis

September 26, 2025
Vol.51 No.35
Clinical Roundup

Mammograms may benefit women well into their 80s, UCLA study finds

September 26, 2025
Vol.51 No.35
Clinical Roundup

How AI will transform mental health support for breast cancer patients, narrative review paper details

September 19, 2025
Vol.51 No.34
VCU Massey, MD Anderson researchers awarded $7.3M grant to launch breast cancer clinical trial
In Brief

VCU Massey, MD Anderson researchers awarded $7.3M grant to launch breast cancer clinical trial

September 12, 2025
Vol.51 No.33
Clinical Roundup

MammaPrint predicts chemotherapy benefit in HR+HER2 early breast cancer patients, observational FLEX study finds

September 05, 2025
Vol.51 No.32

Posts navigation

Previous1…345…32Next

Trending Stories

  • HHS Secretary Kennedy’s diet advice is heavy on meat and light on scientific consensus
  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
  • “This is not about protecting life”: Supreme Court overturn of Roe v. Wade threatens lives of cancer patients, doctors
  • Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
    NCI expects record-breaking spending on extramural research
  • President’s budget request would cap indirect costs and fully fund all NIH research projects upfront

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account